Latest Interviews
Showing 1–5 of 5 transcripts.
Clear all filters- Goldman Sachs11 min
Biotech and the Transition from Pandemic to Endemic
The event analyzes the global transition toward an endemic phase for COVID-19, highlighting a significant disparity where Western nations with high immunization rates differ from the majority of countries in Africa, Asia, and Latin America that remain in the pandemic stage. Industry leaders at BioNTech, Pfizer, and Moderna are currently developing multivalent mRNA vaccines to merge seasonal flu and coronavirus protection, shifting strategies toward frequent boosters to manage waning immunity. The discussion underscores the unprecedented speed of regulatory transparency and clinical development achieved last year while warning against complacency as the world prepares for future pandemic threats.
- Goldman Sachs8 min
Carbon Offsets and the Climate Transition
The carbon offset market functions as a temporary financial bridge for heavy industries unable to immediately decarbonize, offering compliance and voluntary options ranging from renewable investments to forestry projects. Despite growing shareholder pressure and expanded Scope 3 reporting mandates, the sector faces significant skepticism regarding pricing volatility, verification risks, and its inability to fundamentally shift business models. While Asian companies lag in adopting climate targets, global firms in steel, cement, and transportation face future margin contractions as carbon prices rise, necessitating a strategic pivot away from reliance on offsets toward genuine operational decarbonization.
- Goldman Sachs11 min
The Scale and State of the Semiconductor Industry
Facing a projected 10% semiconductor industry decline in 2020 driven by pandemic-induced global GDP contraction, market dynamics have diverged with robust cloud computing demand offsetting weakness in handsets and automotive sectors. While the supply chain demonstrated unexpected resilience outside of specific disruptions in Wuhan, Malaysia, and the Bay Area, geopolitical trade restrictions and US-China tensions continue to create significant regulatory uncertainty for major OEMs like Huawei. Simultaneously, competitive pressures have intensified as top buyers consolidate purchasing power and tech giants vertically integrate their chip designs, shifting the battlefield toward advanced manufacturing triopolies and diversified data center compute cycles.
- Goldman Sachs8 min
Telehealth’s Rapid Rise
Telehealth has rapidly expanded from primary care to encompass mental health, chronic disease management, and biopharma engagement through employer benefits, direct-to-consumer models, and integrated hospital systems. Regulatory shifts during the pandemic, including Medicare reimbursement parity and cross-state licensing, removed historical barriers while maintaining HIPAA compliance to address privacy concerns. This evolution drives long-term cost reductions by prioritizing home-based care and improving access for underserved populations, although certain specialties like anesthesiology remain physically constrained to in-person interactions.
- Goldman Sachs11 min
India’s Response to the Economic Downturn
Goldman Sachs revised India's FY21 growth forecast to 1.6% after projecting a 220 basis point contraction from the nationwide lockdown and 150 basis points from global contagion, marking a deeper downturn than historical recessions but milder than the 1979 decline. The outlook anticipates a severe Q1 and Q2 recession followed by a H2 recovery dependent on infection control, expanded fiscal stimulus beyond the initial 0.8% GDP package, and continued monetary easing by the Reserve Bank of India. While Foreign Institutional Investors have withdrawn over $17 billion, the Indian Rupee remains relatively resilient due to a benign current account deficit and substantial foreign exchange reserves, though short-term depreciation is expected before stabilizing at approximately 72 INR/USD within a year.